ALT-110: Phase I data

In an open-label, U.S. Phase I trial in 16 patients with malignant

Read the full 120 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE